ReviewMedical science monitor : international medical journal of experimental and clinical research2025
Gut Microbiota in Exercise-Regulated Development, Progression, and Management of Type 2 Diabetes Mellitus: A Review of the Role and Mechanisms.
Review in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The effects of high-intensity interval training on glucose metabolism, inflammatory responses, and functional recovery in patients with diabetic peripheral neuropathy.Frontiers in endocrinology · 2026Trial
- The interaction of intestinal microbiota and diabetes mellitus: A database-based quantitative analysis and visualization.Pakistan journal of medical sciences · 2026Article
- Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.Frontiers in microbiology · 2026Review
- Article
- A study on the role of Tai Chi training in improving type 2 diabetes mellitus.Frontiers in public health · 2026Article
- The multi-pathway treatment of flavonoids as natural compounds in neurological diseases: achievements, limitations, and prospects.Frontiers in neuroscience · 2025Review
- Exercise intervention regulates gut microbiota to improve type 2 diabetes: a narrative review of the mechanisms.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Imbalance of the gut microbiota is considered a possible factor in the rapid progression of insulin resistance in type 2 diabetes mellitus (T2DM). Dysbiosis of the gut microbiota can alter intestinal barrier function and host metabolism, as well as signaling pathways in T2DM patients, which are directly or indirectly associated with insulin resistance. Additionally, symbiotic fungi and opportunistic bacteria can stimulate the local immune system, increasing intestinal permeability and leading to gut leakage. This, in turn, activates systemic inflammation and contributes to insulin resistance. Exercise is known to play a crucial role in disease prevention and blood glucose control, as well as in managing diabetes-related organ complications. Aerobic exercise, in particular, is commonly used to prevent and control diabetes by enhancing skeletal muscle responsiveness to insulin through the upregulation of enzymes involved in cellular glucose utilization. Various forms of exercise can also alter the composition and function of the gut microbiota. This paper focuses on the relationship between the gut microbiota and T2DM, the impact of exercise on gut microbiota, and the role of the gut microbiota in exercise-induced improvement of T2DM, aiming to review the role and mechanisms of the gut microbiota in exercise-regulated development, progression, and management of T2DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.